• #NORDsummit – Despite Criticism, Orphan Drug Act Is Working to Advance Needed Treatments, FDA Says
  • Enbrel Treatment Leads to Early Reparative Response in Patients with Non-Radiographic Axial Spondyloarthritis
  • CreakyJoints Releases Guide, Made by Patients, Reviewed by Rheumatologists
  • Taiwanese Study Links Ankylosing Spondylitis to Higher Risk of Certain Cancers
  • MEFV Gene Mutation May Make People More Susceptible to Developing AS, Study Indicates
  • Xeljanz Shows Promise for Ankylosing Spondylitis in Phase 2 Trial
  • Cyltezo, a Humira Biosimilar, Receives Positive Opinion from European CHMP
  • Low BMI in Axial Spondyloarthritis Patients Linked to Weaker Bones, Study Suggests
  • Axial Spondyloarthritis Patients Who are Obese Don’t Do as Well on TNF Blockers, Study Reports
  • Patients with Chronic Inflammatory Disorders at Greater Risk for Heart Disease, Diabetes, Study Finds
  • E.U. Approves Imraldi, a Humira Biosimilar, for Ankylosing Spondylitis, Other Inflammatory Diseases
  • Canada Approves Etanercept Biosimilar Erelzi for Treatment of Ankylosing Spondylitis